Dashboard
Manage Tickers

IGC


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

igc-pharma-expands-ongoing-phase-2-calma-clinical-trial-evaluating-investigational-drug-candidate-igc-ad1-for-agitation-in-alzheimers-disease
IGC Pharma Expands Ongoing Phase 2 CALMA C...
10/14/2025 13:02:07

IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE:IGC), a clinical-stage biotechnology com...

igc-pharma-reports-in-vitro-data-supporting-igc-1c-as-tau-llps-modulator-in-alzheimers-disease
IGC Pharma Reports In-Vitro Data Supportin...
10/07/2025 13:04:59

igc-pharma-unit-enters-sale-of-assets-agreement-for-27m
IGC Pharma Unit Enters Sale Of Assets Agre...
10/01/2025 20:46:58

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001326205/000118518525001326/igc8k100125.htm

igc-pharma-adds-new-clinical-trial-site-to-ongoing-phase-2-study-evaluating-igc-ad1-investigational-drug-candidate-for-treating-agitation-in-alzheimers-disease
IGC Pharma Adds New Clinical Trial Site To...
09/29/2025 13:15:35

IGC Pharma, Inc. (NYSE: IGC) today announced the addition of a new clinical trial site to its ongoing Phase 2 study evaluating ...

igc-pharma-releases-preclinical-data-on-tgr-63-showing-it-impacts-beta-amyloid-pathology-and-inhibits-tau-protein-aggregation-addressing-two-hallmarks-of-alzheimers-disease
IGC Pharma Releases Preclinical Data On TG...
09/24/2025 13:08:48

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

igc-pharma-reports-tgr-63-blocks-both-amyloid-and-tau-aggregation-in-alzheimers-advances-dual-action-therapy-approach
IGC Pharma Reports TGR-63 Blocks Both Amyl...
09/24/2025 13:06:42

IGC Pharma, Inc. (NYSE:IGC) today announced preclinical findings on TGR-63, the Company's investigational small-molecule ca...

Core News & Articles
Governor Newsom Signs Legislation Cutting ...
09/22/2025 17:25:04

https://www.gov.ca.gov/2025/09/22/governor-newsom-signs-legislation-cutting-taxes-on-cannabis-promoting-the-long-term-success-o...

igc-pharma-reaches-50-patient-enrollment-milestone-in-phase-2-calma-alzheimers-agitation-trial
IGC Pharma Reaches 50% Patient Enrollment ...
09/22/2025 13:08:48

Core News & Articles
'Marijuana Industry Group Pushes Congress ...
09/18/2025 18:16:35

https://www.marijuanamoment.net/marijuana-industry-group-pushes-congress-for-tax-relief-and-to-apply-the-fix-retroactively-for-...

Core News & Articles
'Trump's Drug Czar Pick Says Marijuana Is ...
09/17/2025 17:26:10

https://www.marijuanamoment.net/trumps-drug-czar-pick-says-marijuana-is-a-bipartisan-issue-but-admin-still-exploring-all-option...

Core News & Articles
Marijuana Herald Founder And Editor-in-Chi...
09/11/2025 18:04:53

https://x.com/AMartinelliWA/status/1966198351692763194

igc-pharma-announces-expansion-of-ongoing-phase-2-clinical-trial-evaluating-igc-ad1-to-new-international-site-at-island-healths-royal-jubilee-hospital-in-victoria-british-columbia-canada
IGC Pharma Announces Expansion Of Ongoing ...
09/02/2025 13:08:54

igc-pharma-receives-notice-of-allowance-for-patent-application-for-thc-microdose-based-treatment-for-stammering-stuttering-and-tourettes
IGC Pharma Receives Notice Of Allowance Fo...
08/28/2025 13:06:34

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/27/2025 17:06:12

ascendiant-capital-maintains-buy-on-igc-pharma-raises-price-target-to-45
Ascendiant Capital Maintains Buy on IGC Ph...
08/26/2025 10:07:54

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $4.25 to $...

igc-pharma-announces-expansion-of-its-ongoing-phase-2-clinical-trial-evaluating-igc-ad1-for-treating-agitation-in-patients-with-alzheimers-disease
IGC Pharma Announces Expansion Of Its Ongo...
08/25/2025 13:04:58

IGC Pharma, Inc. (NYSE:IGC) today announced the expansion of its ongoing Phase 2 clinical trial evaluating IGC-AD1, an investig...

Core News & Articles
'New Republican National Committee Chairma...
08/22/2025 16:03:13

https://www.marijuanamoment.net/new-republican-national-committee-chairman-supports-marijuana-legalization/

Core News & Articles
'Congressional Staffers Predict Cannabis R...
08/18/2025 18:16:14

https://themarijuanaherald.com/2025/08/staffers-cannabis/

igc-pharma-q1-eps-002-beats-003-estimate-sales-328000k-beat-326000k-estimate
IGC Pharma Q1 EPS $(0.02) Beats $(0.03) Es...
08/14/2025 20:13:05

IGC Pharma (AMEX:IGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 20...

Core News & Articles
'Key Voices In Trump's MAGA Movement Are D...
08/14/2025 19:20:17

https://www.marijuanamoment.net/key-voices-in-trumps-maga-movement-are-divided-on-marijuana-as-president-considers-rescheduling...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION